MARKET

GMED

GMED

Globus Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

45.85
+0.28
+0.61%
After Hours: 45.66 -0.19 -0.41% 19:50 07/10 EDT
OPEN
45.46
PREV CLOSE
45.57
HIGH
45.91
LOW
44.93
VOLUME
506.51K
TURNOVER
--
52 WEEK HIGH
60.15
52 WEEK LOW
33.41
MARKET CAP
4.46B
P/E (TTM)
31.68
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GMED stock price target is 56.50 with a high estimate of 67.00 and a low estimate of 50.00.

EPS

GMED News

More
Piper Sandler Downgrades Globus Medical to Neutral, Lowers Price Target to $50
Piper Sandler analyst Matt O'Brien downgrades Globus Medical (NYSE:GMED) from Overweight to Neutral and lowers the price target from $60 to $50.
Benzinga · 6d ago
3 Big Data Health Stocks to Watch in 2020
MotleyFool.com · 06/24 04:00
Hedge Funds Are Selling Globus Medical Inc (GMED)
In this article we will take a look at whether hedge funds think Globus Medical Inc (NYSE:GMED) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars
Insider Monkey · 06/23 23:40
Why Hertz Stock Is Up
MotleyFool.com · 06/17 04:00
Globus Medical Faces Business Loss Amid Coronavirus Crisis
Zacks · 06/09 15:05
New Strong Sell Stocks for May 27th
Zacks · 05/27 13:09
Edited Transcript of GMED earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/20 14:37
Globus Medical, Inc. (GMED) CEO Dave Demski on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 03:34

Industry

Medical Equipment, Supplies & Distribution
-0.07%
Healthcare Equipment & Supplies
-0.31%

Hot Stocks

Symbol
Price
%Change

About GMED

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.
More

Webull offers kinds of Globus Medical Inc stock information, including NYSE:GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.